Cov lus qhia
| Cwj pwm: | Tawm-dawb rau cov hmoov dawb dawb |
| Purity: | 99.0% min |
| Poob rau ziab: | 0.5% max |
| Residue ntawm ignition: | 0.5% max |
| Unspecified impurity: | 0.2% max |
| Tag nrho cov impurities: | 1.0% max |
Cov Ntaub Ntawv Thauj
|
Chaw ua uas tsis tau haus |
Kev qhia tshwj xeeb |
|
UN NUM |
|
|
Hom |
|
|
Cov Pab Pawg |
|
|
Hs code |
2924199090305 |
|
Ruaj khov & rov ua |
Cov khoom lag luam ruaj khov nyob rau hauv cov qauv ambient ambient. |
|
Chaw ntim khoom |
-20 degree |
|
Mob kom tsis txhob |
|
|
Lub thawv |
Cov Ntawv Thov
1. Kev Kho Mob Cancer
Lenvatinib yog cov tshuaj tiv thaiv tshuaj tiv thaiv tshuaj siv hauv kev kho mob ntawm ntau cov qog. Nws tau pom zoo rau kev siv nyob rau hauv ntau hom kev ua tiav siab los yog metastatic cancers, suav nrog:
■ Cov Ntshav Qhab
Pom zoo rau cov iodineating iodine-refractory txawv teb qog nqaij hlav cancer (Rai-Refractory DTC).
Txhim kho kev ua kom tiav-muaj txoj sia nyob sib txawv piv rau cov placebo.
■ Hepatocellular Carcinoma (HCC)
Siv ua thawj-kab kev rau kev kho mob rau kev zam lub siab mob qog noj ntshav.
Qhia tias tsis yog qhov chaw qis dua rau Sorafeni hauv chaw kuaj mob (piv txwv li, xav txog kev sib tw).
Cell Carcinoma (RCC)
Siv hauv kev sib xyaw nrog aturalolimus lossis pembrolizumab rau kev tshaj lij RCC.
Muab cov hom phiaj adjective teb thiab tag nrho txoj sia.
■ Enderomety Cancer
Pom zoo hauv kev sib xyaw nrog Pembrolizumab rau kev ua tiav lossis rov ua dua qhov kawg
Cov txiaj ntsig
1. Lub hom phiaj kho
Tshwj xeeb ua rau cov kab mob cancer-tsav, txo kev puas tsuaj rau cov hlwb ib txwm piv rau kev siv tshuaj kho kev kho mob.
2. Cov kev ua haujlwm tiv thaiv kab mob
Muaj txiaj ntsig thoob plaws ntau hom Cancer vim nws lub hom phiaj ntau.
3. Qhov ncauj tswj hwm
Muab raws li kev siv tshuaj ntsiav niaj hnub, uas yooj yim dua li cov kev kho mob ntawm cov khoom noj.
4. Synergistic hauv kev kho kev kho
Muaj peev xwm ua tau zoo ntawm kev tiv thaiv kab mob (piv txwv li, pembrolizumab), ua kom cov kev kho mob sib txuas.
5. Txhim kho cov txiaj ntsigmhaw cov txiaj ntsig
Nce muaj kev vam meej-dawb ciaj sia (PFS) thiab tag nrho cov lus teb teb (OR) hauv ntau hom mob cancer.
Feem ntau xaiv cov kab kev xaiv thaum kev phais mob tsis yog ua tau lossis kab mob yog kev tsim kho kom tau saib xyuas.
Tag
Lenvatinib (CAS 417716-92-8) yog muaj zog, muaj ntau hom kev sib tw Kinase inhibitor siv hauv oncology. Nws ua lub luag haujlwm tseem ceeb hauv kev kho mob ntawm cov qog ua lub qog, raum, thiab cov qog nqaij hlav, thiab cov qog nqaij hlav qog ua ke. Nws cov txiaj ntsig, tshwj xeeb yog thaum ua ke nrog kev tiv thaiv kab mob, ua rau nws lub hauv paus rau hauv kev tswj hwm ntawm ntau cov qog nqaij hlav.
Cim npe nrov: Lenvatinib 丨 CAS 417716-92-8, Suav Lenvatinib 丨 CAS 417716-92-8 manufacturers, cov chaw tsim khoom, Hoobkas
